{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T09:00:25Z","timestamp":1771578025508,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":1827,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/jto.0b013e3181f2a266","type":"journal-article","created":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T14:13:43Z","timestamp":1287497623000},"page":"1894-1904","source":"Crossref","is-referenced-by-count":58,"title":["Proteomic Profiling Identifies Pathways Dysregulated in Non-small Cell Lung Cancer and an Inverse Association of AMPK and Adhesion Pathways with Recurrence"],"prefix":"10.1016","volume":"5","author":[{"given":"Meera","family":"Nanjundan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren Averett","family":"Byers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris R.","family":"Siwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Gabriela","family":"Raso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixia","family":"Diao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin R.","family":"Coombes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack A.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon B.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio I.","family":"Wistuba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Minna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John V.","family":"Heymach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e3181f2a266_bib1","series-title":"Cancer Facts & Figures 2008","author":"American Cancer Society","year":"2008"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1200\/JCO.2005.04.177","article-title":"Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data","volume":"23","author":"Hoang","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib4","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer","volume":"26","author":"Scagliotti","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib5","first-page":"2298","article-title":"Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors","volume":"8","author":"Chen","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0140-6736(03)14068-8","article-title":"Proteomic patterns of tumour subsets in non-small-cell lung cancer","volume":"362","author":"Yanagisawa","year":"2003","journal-title":"Lancet"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1440-1843.2006.00957.x","article-title":"Proteomics analysis in lung cancer: challenges and opportunities","volume":"12","author":"Kikuchi","year":"2007","journal-title":"Respirology"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/jnci\/djk197","article-title":"A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer","volume":"99","author":"Yanagisawa","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1074\/mcp.T500003-MCP200","article-title":"Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma","volume":"4","author":"Sheehan","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrd891","article-title":"Clinical proteomics: translating benchside promise into bedside reality","volume":"1","author":"Petricoin","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib11","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1158\/1535-7163.MCT-06-0334","article-title":"Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells","volume":"5","author":"Tibes","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib12","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1172\/JCI21739","article-title":"Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer","volume":"117","author":"Chu","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib13","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1158\/1078-0432.CCR-07-0760","article-title":"Pharmacodynamic markers of perifosine efficacy","volume":"13","author":"Hennessy","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ccr.2007.08.030","article-title":"A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer","volume":"12","author":"Berns","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib15","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1158\/1078-0432.CCR-09-0767","article-title":"Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancer","volume":"15","author":"Byers","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1006\/bbrc.1999.0236","article-title":"Reduction of caveolin 1 gene expression in lung carcinoma cell lines","volume":"255","author":"Racine","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.lungcan.2007.07.024","article-title":"Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy","volume":"59","author":"Ho","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.canlet.2004.04.017","article-title":"Difference of caveolin-1 expression pattern in human lung neoplastic tissue. Atypical adenomatous hyperplasia, adenocarcinoma and squamous cell carcinoma","volume":"214","author":"Kato","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1440-1827.2005.01784.x","article-title":"Loss of expression of E-cadherin and beta-catenin is associated with progression of pulmonary adenocarcinoma","volume":"55","author":"Awaya","year":"2005","journal-title":"Pathol Int"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1535-6108(03)00304-0","article-title":"Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion","volume":"4","author":"Lu","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib21","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1038\/sj.onc.1210418","article-title":"Prevalence and specificity of LKB1 genetic alterations in lung cancers","volume":"26","author":"Matsumoto","year":"2007","journal-title":"Oncogene"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nature06030","article-title":"LKB1 modulates lung cancer differentiation and metastasis","volume":"448","author":"Ji","year":"2007","journal-title":"Nature"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1158\/1535-7163.MCT-05-0347","article-title":"Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways","volume":"5","author":"Han","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib24","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/onc.2009.63","article-title":"Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells","volume":"28","author":"Zhou","year":"2009","journal-title":"Oncogene"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib25","doi-asserted-by":"crossref","first-page":"11630","DOI":"10.1158\/0008-5472.CAN-07-2401","article-title":"Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin","volume":"67","author":"Jin","year":"2007","journal-title":"Cancer Res"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib26","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1200\/JCO.2005.02.857","article-title":"Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib","volume":"23","author":"Eberhard","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib27","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/modpathol.3800041","article-title":"Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry","volume":"17","author":"Deeb","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib28","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1158\/1535-7163.MCT-06-0678","article-title":"Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer","volume":"6","author":"Zhang","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0076-6879(05)03017-X","article-title":"Assay of Rab25 function in ovarian and breast cancers","volume":"403","author":"Cheng","year":"2005","journal-title":"Methods Enzymol"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib30","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/bioinformatics\/btm283","article-title":"Non-parametric quantification of protein lysate arrays","volume":"23","author":"Hu","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B"},{"key":"10.1097\/JTO.0b013e3181f2a266_bib32","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/bioinformatics\/btg148","article-title":"Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-values","volume":"19","author":"Pounds","year":"2003","journal-title":"Bioinformatics"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415318608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415318608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T21:56:57Z","timestamp":1740607017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415318608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1556086415318608"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e3181f2a266","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}